Importantly, two GCB-like DLBCL cell lines that were highly sensitive to EP300 knockout harboured mutations (WSUDLCL2) or copy number variation (CNV) loss (SUDHL5) in CREBBP (Fig. 5B and Supplementary Table S6). The gene discussed is EP300; the disease is diffuse large B-cell lymphoma.